Clinical Trial Update: Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Alleance (atropine sulfate 0.01%) to delay myopia progression and axial elongation in children; the study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia
• Progressive Myopia

Drugs mentioned

• Alleance (Atropine sulfate 0.01%)

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Myopia, Myopia, Progressive | Phase 3 | Status: RECRUITING